📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: OncoZenge

1.1 - Company Overview

OncoZenge Logo

OncoZenge

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of supportive care products for cancer patients. Swedish pharmaceutical company developing BupiZenge™, a lozenge designed to provide local pain relief for oral mucositis, a common side effect of radiotherapy and chemotherapy.

Products and services

  • Supportive Care Product Development: OncoZenge develops better pharmaceutical-grade products for the supportive care of cancer patients, creating products aligned to radiotherapy and chemotherapy side-effect management
  • Oncology Supportive Care Programs: The Swedish pharmaceutical company produces and advances supportive care products for cancer patients undergoing radiotherapy and chemotherapy, emphasizing oral mucositis pain management using an oncology-focused approach
  • BupiZenge™: A lozenge engineered to deliver local pain relief for patients suffering from oral mucositis, a common side effect of radiotherapy and chemotherapy, as an oral-dosage-form

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to OncoZenge

Insys Therapeutics Logo

Insys Therapeutics

HQ: United States Website
  • Description: Provider of specialty pharmaceuticals, developing and commercializing innovative supportive care products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Insys Therapeutics company profile →
Pharmacopeia Logo

Pharmacopeia

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery and development focused on therapeutics addressing significant medical needs, including an internal program portfolio led by PS433540, a dual-acting angiotensin and endothelin receptor antagonist in phase II clinical development for cardiovascular and renal indications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharmacopeia company profile →
Pinteon Therapeutics Logo

Pinteon Therapeutics

HQ: United States Website
  • Description: Provider of a monoclonal antibody therapeutic, PNT001, targeting cis-pT231 tau to reduce neurodegeneration and cognitive impairment in traumatic brain injury, chronic traumatic encephalopathy, Alzheimer's disease, and progressive supranuclear palsy; advancing clinical studies of this novel antibody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pinteon Therapeutics company profile →
Harbor Therapeutics Logo

Harbor Therapeutics

HQ: United States Website
  • Description: Provider of a proprietary class of adrenal steroid hormones developed as novel pharmaceuticals and potential nutraceuticals for human health.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Harbor Therapeutics company profile →
Tolmar Logo

Tolmar

HQ: United States Website
  • Description: Provider of pharmaceutical research, development, manufacturing and commercial operations, delivering proprietary and generic products in dermatology, oncology, and dental therapeutics, including ELIGARD (leuprolide acetate for prostate cancer), Fensolvi (leuprolide acetate for central precocious puberty), and topical dermatology generics—ointments, creams, gels, and lotions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tolmar company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for OncoZenge

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to OncoZenge

2.2 - Growth funds investing in similar companies to OncoZenge

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for OncoZenge

4.2 - Public trading comparable groups for OncoZenge

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to OncoZenge

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About OncoZenge

What does OncoZenge do?

OncoZenge is a provider of supportive care products for cancer patients. Swedish pharmaceutical company developing BupiZenge™, a lozenge designed to provide local pain relief for oral mucositis, a common side effect of radiotherapy and chemotherapy.

Who are OncoZenge's competitors?

OncoZenge's competitors and similar companies include Insys Therapeutics, Pharmacopeia, Pinteon Therapeutics, Harbor Therapeutics, and Tolmar.

Where is OncoZenge headquartered?

OncoZenge is headquartered in Sweden.

How many employees does OncoZenge have?

OncoZenge has 1,000 employees 🔒.

When was OncoZenge founded?

OncoZenge was founded in 2010 🔒.

What sector and industry vertical is OncoZenge in?

OncoZenge is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for OncoZenge

Who are the top strategic acquirers in OncoZenge's sector and industry

Top strategic M&A buyers and acquirers in OncoZenge's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for OncoZenge?

Top strategic M&A buyers groups and sectors for OncoZenge include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in OncoZenge's sector and industry vertical

Which are the top PE firms investing in OncoZenge's sector and industry vertical?

Top PE firms investing in OncoZenge's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in OncoZenge's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in OncoZenge's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in OncoZenge's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to OncoZenge include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in OncoZenge's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for OncoZenge?

The key public trading comparables and valuation benchmarks for OncoZenge include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for OncoZenge for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for OncoZenge with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in OncoZenge's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for OncoZenge with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in OncoZenge's' sector and industry vertical?

Access recent funding rounds and capital raises in OncoZenge's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for OncoZenge